Presentation is loading. Please wait.

Presentation is loading. Please wait.

EPA treatment rescued LPL RNAi–induced suppression of MTCOI protein expression. EPA treatment rescued LPL RNAi–induced suppression of MTCOI protein expression.

Published byKaisa Karjalainen Modified over 5 years ago

Similar presentations

Presentation on theme: "EPA treatment rescued LPL RNAi–induced suppression of MTCOI protein expression. EPA treatment rescued LPL RNAi–induced suppression of MTCOI protein expression."— Presentation transcript:

1 EPA treatment rescued LPL RNAi–induced suppression of MTCOI protein expression.
EPA treatment rescued LPL RNAi–induced suppression of MTCOI protein expression. L6 myotubes were incubated with EPA (50 μmol/L), DHA (50 μmol/L), or 0.125% BSA for 48 h after LPL and CD36 RNAi treatment (50 nmol/L). MTCOI protein expressions were measured by Western blotting (n = 9). Results represent mean ± SEM. *P < 0.05, ***P < Katsutaro Morino et al. Diabetes 2012;61: ©2012 by American Diabetes Association

Download ppt "EPA treatment rescued LPL RNAi–induced suppression of MTCOI protein expression. EPA treatment rescued LPL RNAi–induced suppression of MTCOI protein expression."

Similar presentations

Enhanced DNA damage in IDH1 mutant glioma cells.

Enhanced DNA damage in IDH1 mutant glioma cells.
Inhibition of ILK restores epithelial ZO-1 and E-cadherin and inhibits fibronectin and Snail1 expression after TGF-β1 treatment. Inhibition of ILK restores.

Inhibition of ILK restores epithelial ZO-1 and E-cadherin and inhibits fibronectin and Snail1 expression after TGF-β1 treatment. Inhibition of ILK restores.
Inhibition of ILK by QLT-0267 abrogates PAI-1 and MMP-2 induction by TGF-β1 in tubular epithelial cells. Inhibition of ILK by QLT-0267 abrogates PAI-1.

Inhibition of ILK by QLT-0267 abrogates PAI-1 and MMP-2 induction by TGF-β1 in tubular epithelial cells. Inhibition of ILK by QLT-0267 abrogates PAI-1.
Cetuximab treatment increases IFNγ receptor 1 expression.

Cetuximab treatment increases IFNγ receptor 1 expression.
Suppressive effect of CD39+CD73+ melanoma cells on T-cell proliferation, and reversion of this effect via treatment with the CD39-blocking antibody, CD39.

Suppressive effect of CD39+CD73+ melanoma cells on T-cell proliferation, and reversion of this effect via treatment with the CD39-blocking antibody, CD39.
Rapamycin inhibits TCR/CD3 engagement-dependent HIF-1α protein expression. Rapamycin inhibits TCR/CD3 engagement-dependent HIF-1α protein expression. Human.

Rapamycin inhibits TCR/CD3 engagement-dependent HIF-1α protein expression. Rapamycin inhibits TCR/CD3 engagement-dependent HIF-1α protein expression. Human.
Effect of Z-FA-FMK on the expression of SMN proteins in SMA patient iPSCs and iPSC-derived motor neurons. Effect of Z-FA-FMK on the expression of SMN proteins.

Effect of Z-FA-FMK on the expression of SMN proteins in SMA patient iPSCs and iPSC-derived motor neurons. Effect of Z-FA-FMK on the expression of SMN proteins.
Identification of Z-FA-FMK as a potent compound that increases SMN protein expression in HEK293 and patient fibroblast cells. Identification of Z-FA-FMK.

Identification of Z-FA-FMK as a potent compound that increases SMN protein expression in HEK293 and patient fibroblast cells. Identification of Z-FA-FMK.
Effect of insulin on hepcidin expression in HepG2 cells.

Effect of insulin on hepcidin expression in HepG2 cells.
(A) Glucose values (mean +SEM) during continuous glucose monitoring while consuming whey protein (solid lines and filled circles) or placebo (broken lines.

(A) Glucose values (mean +SEM) during continuous glucose monitoring while consuming whey protein (solid lines and filled circles) or placebo (broken lines.
Effect of 14 hit compounds on SMN protein expression in type I SMA patient fibroblast cells (GM03813). Effect of 14 hit compounds on SMN protein expression.

Effect of 14 hit compounds on SMN protein expression in type I SMA patient fibroblast cells (GM03813). Effect of 14 hit compounds on SMN protein expression.
P38 activation mediates chronic insulin-induced IRS1 and IRS2 degradation and is involved in myocardial insulin resistance in vitro. p38 activation mediates.

P38 activation mediates chronic insulin-induced IRS1 and IRS2 degradation and is involved in myocardial insulin resistance in vitro. p38 activation mediates.
Rosiglitazone induces Pdk4 expression in rat and human adipose tissue ex vivo and in 3T3–F442A adipocytes. Rosiglitazone induces Pdk4 expression in rat.

Rosiglitazone induces Pdk4 expression in rat and human adipose tissue ex vivo and in 3T3–F442A adipocytes. Rosiglitazone induces Pdk4 expression in rat.
Fatty acid incorporation into triglycerides, triglyceride content, glycerol release, and fatty acid efflux in wild-type and +CD36 myotubes. Fatty acid.

Fatty acid incorporation into triglycerides, triglyceride content, glycerol release, and fatty acid efflux in wild-type and +CD36 myotubes. Fatty acid.
Ion channels expression and insulin secretion in the pancreatic islets of male offspring. Ion channels expression and insulin secretion in the pancreatic.

Ion channels expression and insulin secretion in the pancreatic islets of male offspring. Ion channels expression and insulin secretion in the pancreatic.
Expression of SENP2 mRNA is regulated by palmitate-induced NF-κB activation. Expression of SENP2 mRNA is regulated by palmitate-induced NF-κB activation.

Expression of SENP2 mRNA is regulated by palmitate-induced NF-κB activation. Expression of SENP2 mRNA is regulated by palmitate-induced NF-κB activation.
Effects of Z-FA-FMK on SMN protein expression in type II SMA patient fibroblast cells (GM22592). Effects of Z-FA-FMK on SMN protein expression in type.

Effects of Z-FA-FMK on SMN protein expression in type II SMA patient fibroblast cells (GM22592). Effects of Z-FA-FMK on SMN protein expression in type.
Influence of insulin on AdipoR1 mRNA expression in murine C2C12 myotubes. Influence of insulin on AdipoR1 mRNA expression in murine C2C12 myotubes. Data.

Influence of insulin on AdipoR1 mRNA expression in murine C2C12 myotubes. Influence of insulin on AdipoR1 mRNA expression in murine C2C12 myotubes. Data.
JAK3A572V mutation causes constitutive JAK3 activity and IL-2–independent proliferation of NKTCL cells. JAK3A572V mutation causes constitutive JAK3 activity.

JAK3A572V mutation causes constitutive JAK3 activity and IL-2–independent proliferation of NKTCL cells. JAK3A572V mutation causes constitutive JAK3 activity.
Time-dependent effects of IL-6 on tyrosine phosphorylation of IRS-1.

Time-dependent effects of IL-6 on tyrosine phosphorylation of IRS-1.

Similar presentations

Ads by Google